Literature DB >> 15097294

Deep brain stimulation for psychiatric disorders.

Brian Harris Kopell1, Benjamin Greenberg, Ali R Rezai.   

Abstract

Over the last decade, deep brain stimulation (DBS) has revolutionized the practice of neurosurgery, particularly in the realm of movement disorders. It is no surprise that DBS is now being studied in the treatment of refractory psychiatric disease. Deep brain stimulation has inherent advantages over previous lesioning procedures. It is fully reversible, and stimulation can be adjusted according to a patient's changing symptoms and disease progression. Coupled with the fact that the stimulation can generally be turned on or off without the patient's awareness, DBS provides a unique opportunity for double-blinding studies. To undertake DBS for psychiatric conditions, appropriate surgical targets must be chosen. What is most strongly supported is the role of cortico-striato-thalamocortical (CSTC) loops in the pathophysiology of psychiatric symptoms. Recent functional imaging studies have consistently found evidence that corroborate this model of psychiatric symptom pathogenesis. Based on the psychiatric and cognitive effects seen in recent movement disorder surgery, it is apparent that modulation of neural systems subserving psychiatric phenomenon can be accomplished by DBS. The few published studies on DBS for obsessive-compulsive disorder (OCD) suggest that this can be done safely. While efficacy data are still uncertain, initial data are promising.

Entities:  

Mesh:

Year:  2004        PMID: 15097294     DOI: 10.1097/00004691-200401000-00007

Source DB:  PubMed          Journal:  J Clin Neurophysiol        ISSN: 0736-0258            Impact factor:   2.177


  27 in total

1.  Psychosurgery in the History of Stereotactic Functional Neurosurgery.

Authors:  Lara Rzesnitzek; Marwan Hariz; Joachim K Krauss
Journal:  Stereotact Funct Neurosurg       Date:  2020-06-29       Impact factor: 1.875

2.  Absence of memory dysfunction after bilateral mammillary body and mammillothalamic tract electrode implantation: preliminary experience in three patients.

Authors:  Thierry P Duprez; Basel Abu Serieh; Christian Raftopoulos
Journal:  AJNR Am J Neuroradiol       Date:  2005-01       Impact factor: 3.825

3.  Two-year outcomes of deep brain stimulation in adults with cerebral palsy.

Authors:  Ae Ryoung Kim; Jin Woo Chang; Won Seok Chang; Eun Sook Park; Sung-Rae Cho
Journal:  Ann Rehabil Med       Date:  2014-04-29

Review 4.  Tracking the mechanisms of deep brain stimulation for neuropsychiatric disorders.

Authors:  J Luis Lujan; Ashutosh Chaturvedi; Cameron C McIntyre
Journal:  Front Biosci       Date:  2008-05-01

5.  Deep brain stimulation for obsessive-compulsive disorder and treatment-resistant depression: systematic review.

Authors:  Shaheen E Lakhan; Enoch Callaway
Journal:  BMC Res Notes       Date:  2010-03-04

Review 6.  Deep brain stimulation for treatment-resistant depression: systematic review of clinical outcomes.

Authors:  Takashi Morishita; Sarah M Fayad; Masa-aki Higuchi; Kelsey A Nestor; Kelly D Foote
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

7.  Neurogenic hippocampal targets of deep brain stimulation.

Authors:  Juan M Encinas; Clement Hamani; Andres M Lozano; Grigori Enikolopov
Journal:  J Comp Neurol       Date:  2011-01-01       Impact factor: 3.215

8.  Ablative Limbic System Surgery: Review and Future Directions.

Authors:  Saurabh Sinha; Robert A McGovern; Charles B Mikell; Garrett P Banks; Sameer A Sheth
Journal:  Curr Behav Neurosci Rep       Date:  2015-03-13

9.  Surgical treatment of obsessive compulsive disorders: Current status.

Authors:  Paresh K Doshi
Journal:  Indian J Psychiatry       Date:  2009 Jul-Sep       Impact factor: 1.759

10.  Brain potentials of conflict and error-likelihood following errorful and errorless learning in obsessive-compulsive disorder.

Authors:  Anke Hammer; Andreas Kordon; Marcus Heldmann; Bartosz Zurowski; Thomas F Münte
Journal:  PLoS One       Date:  2009-08-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.